Bangkok Genomics Innovation PCL

฿2.30As of Sun 8 Nov 2026, 12:00 UTC
SET:BKGIHealthcare
Country Thailand
PE (Fwd) •••
TSR 3Y CAGR (11.64%)
Div yield 2.17%
ROE 17.13%
Diagnostics & Research
Beta (5Y) 1.14
PE TTM 14.52
TSR TTM 52.78%
Mkt cap ฿1.380B
ROIC 20.52%
SE Grade™
Value
Quality
Moat
Consensus
Reference
฿2.48
7.96%
(35.10%)
Buy 7|6|4|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share฿
0.04
0.04
0.05
0.05
7.59%
7.53%
8.40%
16.19%
Revenue฿M
82.02
82.13
84.90
89.46
(2.99%)
(0.04%)
4.18%
11.45%
Peers (US$41.28M)
Cap (US$)
PE
61.98M
25.48x
34.63M
11.42x
32.78M
9.009x
40.90M
28.11x
Capital
TTM
5Y
10Y
Leveragex
1.033
(1.033)
(0.872)
EBIT/Intx
11.47
0.058
0.061
Own earn%
104.11
(77.48)
(85.72)
Sh yield%
21.52
55.91
55.06
Owners
Insiders/Inst%
3.64
39.24
Short interest%
3.76
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
26–32
$1 testx
0.1
Incr. ROIC%
13